Anticancer neuroimmunomodulation by pineal hormones other than melatonin: Preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatonin

Journal of Biological Regulators and Homeostatic Agents

Volumn 11, Issue 3, 1997, Pages 119-122

  Lissoni, P ^a   Fumagalli, L ^b   Paolorossi, F ^a   Rovelli, F ^a   Roselli, M G ^a   Maestroni, G J M ^c  

^a SAN GERARDO HOSPITAL   (Italy)

^b CHIRON VACCINES   (Italy)

^c INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

5 methyoxytryptophol; Cancer immunotherapy; Interleukin 2; Melatonin; Pineal gland

Indexed keywords

5 METHOXYTRYPTOPHOL; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MELATONIN; PINEAL BODY HORMONE;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOMODULATION; LIVER CELL CARCINOMA; LUNG CANCER; MALE; MELANOMA; MESOTHELIOMA; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; PROTEIN BLOOD LEVEL; SOLID TUMOR; STOMACH CANCER; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR REGRESSION;

EID: 0031468676     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Brzezinski A. Melatonin in humans. N. Engl. J. Med. 1997; 336: 186-95.
2. Arendt J. Melatonin. Clin Endocrinol 1988; 29: 205-29.
3. Maestroni GJM. The immunoneuroendocrine role of melatonin. J Pineal Res 1993; 14: 1-10.
4. Lissoni P, Pittalis S, Rovelli F et al. Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5-methoxytryptophol. J Biol Regul Homeost Agents 1996; 10: 27-30.
5. Guerrero JM, Rafii-El-Idrissi M, Garcia-Perganeda A et al. Mechanisms of action of melatonin on the human system. Membrane versus nuclear receptors. Front Horm Res 1997; 23: 43-51.
6. Skene DJ, Churchill A, Raynaud F, Pever P, Arendt J. Radioimmunoassay of 5-methoxytryptophol in plasma. Clin Chem 1989; 35: 1749-52.
7. Woitowicz-Praga S. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother 1997; 20: 165-77.
8. Tartour E, Dorval T, Mosseri V et al. Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. Br J Cancer 1994; 69: 911-3.
9. Lissoni P, Ardizzoia A, Barni S et al. Efficacy and tolerability of cancer neuro-immunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin: a progress report of 200 patients with advanced solid neoplasms. Oncol Rep 1995; 2: 1063-8.
10. Sze SF, Ng TB, Liu WK. Antiproliferative effect of pineal indoles on cultured tumor cell lines. J Pineal Res 1993; 14; 27-33.